Shanghai Proton and Heavy Ion Center
31
7
7
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
16.1%
5 terminated/withdrawn out of 31 trials
44.4%
-42.1% vs industry average
10%
3 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (31)
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
Role: collaborator
Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy
Role: lead
Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma
Role: lead
Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
Role: lead
A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.
Role: lead
Carbon Ion RT for Locally Advanced Pancreatic Cancer
Role: collaborator
Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer
Role: lead
Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma
Role: lead
Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer
Role: lead
Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position
Role: lead
Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery
Role: lead
A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer
Role: lead
A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction
Role: lead
Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma
Role: lead
Proton and Carbon Ion Radiotherapy for Cervical Cancer
Role: lead
12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer
Role: lead
Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer
Role: lead
Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
Role: lead
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
Role: lead
Individualized Carbon-Ion Radiotherapy for Patients With Locally Recurrent Nasopharyngeal Carcinoma
Role: lead